Thursday, July 22, 2021 10:38:20 AM
10:31 AM EDT, 07/22/2021 (MT Newswires) --
Zevia PBC said early Thursday it has priced its initial public offering of 10.7 million class A common shares at $14 each, the midpoint of its expected price range of $13 to $15 per share.
The shares are expected to commence trading Thursday on the New York Stock Exchange under the ticker symbol ZVIA.
Underwriters were granted an option to purchase up to 1.605 million more shares in the IPO, which is set to close by Monday.
The stevia-sweetened beverage brand initially planned to sell 14.3 million class A shares in the offering.
Price: 14.00, Change: 0.00, Percent Change: 0.00
Recent ZVIA News
- Zevia to Participate in Upcoming Investor Conferences • Business Wire • 05/01/2024 12:00:00 PM
- Zevia to Announce First Quarter 2024 Results on Wednesday, May 8, 2024 • Business Wire • 04/24/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 09:17:08 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 11:47:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:14:50 PM
- Zevia Announces Fourth Quarter and Full Year 2023 Results • Business Wire • 02/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 12:10:35 PM
- Zevia Appoints Girish Satya as Chief Financial Officer • Business Wire • 02/20/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:05:36 PM
- Zevia to Announce Fourth Quarter and Full Year 2023 Results on Tuesday, February 27, 2024 • Business Wire • 02/13/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:56:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:51:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 09:19:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 09:18:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 09:17:16 PM
- Zevia to Participate in the 26th Annual ICR Conference • Business Wire • 12/27/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 09:46:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:21:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 12:10:09 PM
- Zevia Announces Third Quarter 2023 Results • Business Wire • 11/07/2023 12:00:00 PM
- Zevia to Participate in Stephens Annual Investment Conference • Business Wire • 11/01/2023 12:00:00 PM
- Zevia to Announce Third Quarter 2023 Results on Tuesday, November 7, 2023 • Business Wire • 10/24/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2023 10:04:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/10/2023 12:43:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM